BD光环失效?从先声药业7.45亿美金交易看市场风向突变

医药研究社
Jun 20

为何一笔巨额BD带不动股价?来源|医药研究社投资市场瞬息万变,前段时间都在说医药BD炒热了股市,但近段时间一些药企的BD交易似乎开始遇冷了,比如先声药业。日前该公司宣布,2025年6月16日,其附属公司海南先声再明医药股份有限公司(以下简称“先声再明”)与美国生物制药公司NextCure, Inc.订立许可协议。根据该许可协议,NextCure将拥有先声再明旗下创新抗体偶联药物(ADC)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10